HLD-0915 Receives FDA Fast Track Designation for mCRPC Treatment

4 months ago 55

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted precision medicine strategies.

1. Homepage
2. Prostate Cancer
3. HLD-0915 Receives FDA Fast Track Designation for mCRPC Treatment